Embecta Corp. (EMBC)
11.89
+0.35
(+3.03%)
USD |
NASDAQ |
Dec 11, 13:14
Embecta Market Cap: 695.72M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Becton, Dickinson & Co. | 56.84B |
| AIM ImmunoTech, Inc. | 1.146M |
| Perspective Therapeutics, Inc. | 196.62M |
| Protalix Biotherapeutics, Inc. | 145.56M |
| Armata Pharmaceuticals, Inc. | 214.71M |
Market Cap Related Metrics
| PE Ratio | 7.305 |
| PS Ratio | 0.6453 |
| PEG Ratio | 0.3613 |
| Price to Free Cash Flow | 3.822 |
| Price | 11.89 |
| Earnings Yield | 13.69% |
| PEGY Ratio | 0.2875 |
| Operating PE Ratio | 2.139 |
| Normalized PE Ratio | 4.523 |